NCT00003909View on ClinicalTrials.gov

Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 1999

Primary Completion Date

March 31, 2007

Conditions
Untreated Childhood Brain Stem Glioma
Interventions
DRUG

motexafin gadolinium

Given IV

RADIATION

radiation therapy

Undergo radiation therapy

OTHER

pharmacological study

Correlatives studies

Trial Locations (1)

91006-3776

Children's Oncology Group, Arcadia

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00003909 - Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma | Biotech Hunter | Biotech Hunter